Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK.
Saved in:
| Title: | Cost-effectiveness analysis of vaborem for the treatment of carbapenem-resistant Enterobacteriaceae-Klebsiella pneumoniae carbapenemase (CRE-KPC) infections in the UK. |
|---|---|
| Authors: | Vlachaki I; Menarini Ricerche SpA, Athens, Greece., Zinzi D; Menarini Ricerche SpA, Florence, Italy., Falla E; Real World Solutions, IQVIA Ltd, 37 North Wharf Road, London, W21AF, UK. edel.falla@iqvia.com., Mantopoulos T; Real World Solutions, IQVIA Ltd, Athens, Greece., Guy H; FIECON Ltd, St Albans, UK., Jandu J; FIECON Ltd, St Albans, UK., Dodgson A; Public Health England, Manchester, UK. |
| Source: | The European journal of health economics : HEPAC : health economics in prevention and care [Eur J Health Econ] 2022 Apr; Vol. 23 (3), pp. 537-549. Date of Electronic Publication: 2021 Sep 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 101134867 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-7601 (Electronic) Linking ISSN: 16187598 NLM ISO Abbreviation: Eur J Health Econ Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1618-7601 |
|---|---|
| DOI: | 10.1007/s10198-021-01375-0 |
